Delivery Order SPE2DR25D2104-SPE2DR26F3UFC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,109.63 to AmerisourceBergen Drug Corp for Shingrix vial kits, with completion targeted for December 9, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,102.87 by the Defense Logistics Agency (DLA) on January 8, 2026, for Shingrix vial kits with an ultimate completion date of January 9, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a ceiling value of $1,139.18 and an ultimate completion date of June 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The performance location is also Conshohocken, PA, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,695.90 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,355.01 on September 3, 2025, for the supply of Shingrix vial kits. This competitively awarded, firm fixed-price contract is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 4, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 1, 2025. This firm fixed price contract, awarded on July 31, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $1,139.18, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement to supply vaccines supporting federal medical supply chain requirements. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 8, 2026, for Shingrix vial kits with a ceiling value of $1,198.97. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and does not utilize a set-aside designation. The award was made through open competition, consistent with Amerisourcebergen's established track record as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,993.51 for Shingrix vial kits on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, fulfilling this...
- The Defense Logistics Agency awarded a delivery order valued at $6,440.48 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of December 11, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3UFCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,102.87 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of January 26, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 31, 2031. This prime IDC serves as a comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The Shingrix delivery order reflects the company's role in supplying vaccines and specialized medical commodities across multiple therapeutic domains. The performance location is Conshohocken, PA, where the company maintains its corporate operations that support the fulfillment of federal medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/22/26 |